Australian (ACL) is held by 7 ASX ETFs. Over the last year it rose 17.8%: on $10,000, +$1781. We explain 8 big moves in that time.
About ACL
- SectorHealth Care
- IndustryHealth Care Equipment & Services
- Size$522.3m
- Held by7 ETFs
- Big moves8 in 1Y
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- +5.0%peak +7.1%9 Oct 2026· Stake Change
Citigroup filed a substantial shareholder notice disclosing a 5.12% voting stake in Australian Clinical Labs, signalling new institutional buying interest.
- +14.9%peak +21.7%17 Aug 2026· Earnings Beat
Australian Clinical Labs shares surged after analyst/media coverage highlighting improving margins and an earnings growth outlook despite softer revenue, attracting renewed buyer interest.
- +6.2%16 Jul 2026· Unknown
ACL.AX rose sharply with no clear trigger, as the modest 0.5% gain in the broader healthcare sector index is far too small to explain a 5.5% move, leaving the cause unknown.
- −7.4%16 Feb 2026· Earnings Miss
Australian Clinical Labs (ACL.AX) fell sharply after reporting weaker half-year earnings with margin compression, an interim dividend, and the CEO's departure.
- −5.0%9 Feb 2026· Unknown
No specific news explains the Australian Clinical Labs share price decline.
- −5.5%6 Feb 2026· Unknown
Insufficient evidence to determine the cause of the price move.
- −5.1%5 Jan 2026· Unknown
No specific company announcement or news identified; stock move likely due to broad sector weakness or market factors.
- +8.7%23 Oct 2025· Management
The stock rose 8.7% on the day the company announced the resignation of a board member, likely interpreted as a positive catalyst or coincidental with other unannounced factors.
Held by 7 ETFs
Of every $10,000 in each fund, how much is in ACL today.
- MVSVanEck Small Companies Masters ETF$1711.71%
- SSOSTATE STREET SPDR S&P/ASX SMALL ORDINARIES ETF$180.18%
- ISOiShares S&P/ASX Small Ordinaries ETF$180.18%
- QOZBetaShares FTSE RAFI Australia 200 ETF$7.130.07%
- VETHVanguard Ethically Conscious Australian Shares ETF$2.520.03%
- A300Global X Australia 300 ETF$2.040.02%
- VASVanguard Australian Shares Index ETF$1.780.02%
Why did ACL fall 5.0% on 9 Feb 2026?
Australian
No specific news explains the Australian Clinical Labs share price decline.
The provided news articles mention unrelated companies (HMC Capital, Lendlease, Sonic Healthcare, etc.) and do not reference Australian Clinical Labs or any relevant sector developments. The price move and volume spike appear unrelated to accessible public information, leaving the cause unexplained.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice. It does not consider your objectives, finances or needs. Past performance is not a guide to future performance.
Evidence
News coverage
What it did to the 7 ETFs holding ACL
On $10,000 in each fund, at the weight it holds today